$CRCW
Crypto Co

2024 Q4 Form 10-Q Financial Statement

#000149315224046833 Filed on November 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $10.30K
YoY Change -91.71%
Cost Of Revenue $7.361K
YoY Change -50.6%
Gross Profit $2.938K
YoY Change -97.31%
Gross Profit Margin 28.53%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $28.28K
YoY Change -92.33%
Operating Profit -$25.34K
YoY Change -90.24%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$102.1K
YoY Change -71.54%
Income Tax
% Of Pretax Income
Net Earnings -$102.1K
YoY Change -71.54%
Net Earnings / Revenue -991.8%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 2.584B shares 1.982B shares
Diluted Shares Outstanding 2.008B shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $6.662K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $3.032K
Receivables
Other Receivables
Total Short-Term Assets $9.694K
YoY Change -59.92%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $746.4K
YoY Change 0.8%
Intangibles $509.2K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.256M
YoY Change -2.07%
TOTAL ASSETS
Total Short-Term Assets $9.694K
Total Long-Term Assets $1.256M
Total Assets $1.265M
YoY Change -3.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.037M
YoY Change 19.0%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.037M
Total Long-Term Liabilities
Total Liabilities $6.050M
YoY Change 16.09%
SHAREHOLDERS EQUITY
Retained Earnings -$47.74M
YoY Change 9.86%
Common Stock $42.96M
YoY Change 8.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.785M
YoY Change
Total Liabilities & Shareholders Equity $1.265M
YoY Change -3.15%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$102.1K
YoY Change -71.54%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55726
dei Entity Registrant Name
EntityRegistrantName
THE CRYPTO COMPANY
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-4212105
dei Entity Address Address Line1
EntityAddressAddressLine1
23823 Malibu Road
dei Entity Address Address Line2
EntityAddressAddressLine2
# 50477
dei Entity Address City Or Town
EntityAddressCityOrTown
Malibu
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90265
dei City Area Code
CityAreaCode
(424)
dei Local Phone Number
LocalPhoneNumber
228-9955
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6036982 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5185326 usd
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
125000 usd
CY2024Q3 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
12802 usd
CY2023Q4 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
13333 usd
CY2024Q3 us-gaap Liabilities
Liabilities
6049784 usd
CY2023Q4 us-gaap Liabilities
Liabilities
5323659 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
19000000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2312970914 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2312970914 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
565709873 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
565709873 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
2312971 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
565321 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
40642224 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
39932216 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47739745 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-44446603 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-4784551 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3949066 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1265233 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1374593 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6662 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72970 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
30317 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
103287 usd
CY2023Q4 us-gaap Goodwill
Goodwill
740469 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1989881 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
19000000000 shares
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10299 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
124195 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7361 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14900 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
309364 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
244183 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-3905097 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3949066 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
20435 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001688126
CY2024Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
usd
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
usd
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
usd
CY2024Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
usd
CY2024Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
CY2023Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
CY2024Q3 CRCW Loss On Sale Of Property Plant Equipment
LossOnSaleOfPropertyPlantEquipment
usd
CRCW Loss On Sale Of Property Plant Equipment
LossOnSaleOfPropertyPlantEquipment
usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2584452644 shares
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.001
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3032 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
9694 usd
CY2024Q3 us-gaap Goodwill
Goodwill
746368 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
509171 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
530837 usd
CY2024Q3 us-gaap Assets
Assets
1265233 usd
CY2023Q4 us-gaap Assets
Assets
1374593 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2344245 usd
CY2024Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
959002 usd
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
689002 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
2608735 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2506443 usd
CY2024Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
125000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35946 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
379107 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
16619 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
248136 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
2938 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
109295 usd
us-gaap Gross Profit
GrossProfit
19326 usd
us-gaap Gross Profit
GrossProfit
130971 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
996017 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
979324 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10833 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
21666 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
32499 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
28275 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
368834 usd
us-gaap Operating Expenses
OperatingExpenses
2882782 usd
us-gaap Operating Expenses
OperatingExpenses
1632121 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-25338 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-259539 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2863455 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1501150 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
25775 usd
CRCW Loss On Sale Of Property Plant Equipment
LossOnSaleOfPropertyPlantEquipment
31000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
76807 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
99306 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
470157 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2416621 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-102145 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-358845 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3333613 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3922996 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-102145 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-358845 usd
us-gaap Net Income Loss
NetIncomeLoss
-3333613 usd
us-gaap Net Income Loss
NetIncomeLoss
-3922996 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2007990481 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2007990481 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
110774232 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
110774232 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1339764794 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1339764794 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57709544 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57709544 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3059440 usd
CY2023Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
5.00
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000 usd
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
388075 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
2031499 usd
CRCW Stock Issued During Period Value Loan Payments
StockIssuedDuringPeriodValueLoanPayments
632766 usd
us-gaap Net Income Loss
NetIncomeLoss
-3922996 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3949066 usd
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1243502 usd
CRCW Stock Issued During Period Value Adjustment Of Prior Year Loss
StockIssuedDuringPeriodValueAdjustmentOfPriorYearLoss
40471 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
20997 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1193158 usd
us-gaap Net Income Loss
NetIncomeLoss
-3333613 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-4784551 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-4784551 usd
us-gaap Net Income Loss
NetIncomeLoss
-3333613 usd
us-gaap Net Income Loss
NetIncomeLoss
-3922996 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
21666 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
32499 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1243502 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
620298 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
20997 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2031499 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-31000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-27285 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-77567 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
270000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
360000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
354364 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6518 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1395798 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-763615 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
571936 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
195702 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
757554 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
844146 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1329490 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
673444 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-66308 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-90171 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
72970 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
110606 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6662 usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
1255659 usd
CY2024Q3 us-gaap Cash
Cash
6662 usd
us-gaap Net Income Loss
NetIncomeLoss
-3333613 usd
CRCW Working Capital
WorkingCapital
-6027288 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47739745 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_zjKfaw78REhd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_865_zpo7qXUbJ5ia">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of these condensed consolidated financial statements in conformity with GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses and the related disclosure of contingent assets and liabilities. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company’s significant estimates and assumptions include but are not limited to the valuation allowances of deferred taxes, and share-based compensation expenses. Actual results may differ from these estimates. In addition, any change in these estimates or their related assumptions could have an adverse effect on the Company’s operating results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Goodwill Gross
GoodwillGross
1349457 usd
CY2024Q3 us-gaap Goodwill
Goodwill
746368 usd
CY2024Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
650000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
54166 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
21666 usd
CY2024Q3 us-gaap Convertible Debt
ConvertibleDebt
125000 usd
CY2023Q4 us-gaap Convertible Debt
ConvertibleDebt
125000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2281429 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.26
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y3M
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2281429 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.26
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y9M
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2281429 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.26
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y9M
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
0 usd
us-gaap Payments For Rent
PaymentsForRent
0 usd
us-gaap Payments For Rent
PaymentsForRent
0 usd
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001493152-24-046833-index-headers.html Edgar Link pending
0001493152-24-046833-index.html Edgar Link pending
0001493152-24-046833.txt Edgar Link pending
0001493152-24-046833-xbrl.zip Edgar Link pending
crcw-20240930.xsd Edgar Link pending
ex10-1.htm Edgar Link pending
ex10-1_001.jpg Edgar Link pending
ex10-1_002.jpg Edgar Link pending
ex10-1_003.jpg Edgar Link pending
ex10-1_004.jpg Edgar Link pending
ex10-1_005.jpg Edgar Link pending
ex10-1_006.jpg Edgar Link pending
ex10-1_007.jpg Edgar Link pending
ex10-1_008.jpg Edgar Link pending
ex10-1_009.jpg Edgar Link pending
ex10-1_010.jpg Edgar Link pending
ex10-1_011.jpg Edgar Link pending
ex10-1_012.jpg Edgar Link pending
ex10-1_013.jpg Edgar Link pending
ex10-1_014.jpg Edgar Link pending
ex10-1_015.jpg Edgar Link pending
ex10-1_016.jpg Edgar Link pending
ex10-1_017.jpg Edgar Link pending
ex10-1_018.jpg Edgar Link pending
ex10-1_019.jpg Edgar Link pending
ex10-1_020.jpg Edgar Link pending
ex10-1_021.jpg Edgar Link pending
crcw-20240930_cal.xml Edgar Link unprocessable
crcw-20240930_def.xml Edgar Link unprocessable
crcw-20240930_lab.xml Edgar Link unprocessable
crcw-20240930_pre.xml Edgar Link unprocessable
ex10-1_022.jpg Edgar Link pending
ex10-1_023.jpg Edgar Link pending
ex10-1_024.jpg Edgar Link pending
ex10-1_025.jpg Edgar Link pending
ex10-2.htm Edgar Link pending
ex10-2_001.jpg Edgar Link pending
ex10-2_002.jpg Edgar Link pending
ex10-2_003.jpg Edgar Link pending
ex10-2_004.jpg Edgar Link pending
ex10-2_005.jpg Edgar Link pending
ex10-2_006.jpg Edgar Link pending
ex10-2_007.jpg Edgar Link pending
ex10-2_008.jpg Edgar Link pending
ex10-2_009.jpg Edgar Link pending
ex10-2_010.jpg Edgar Link pending
ex10-2_011.jpg Edgar Link pending
ex10-2_012.jpg Edgar Link pending
ex10-2_013.jpg Edgar Link pending
ex10-2_014.jpg Edgar Link pending
ex10-2_015.jpg Edgar Link pending
ex10-2_016.jpg Edgar Link pending
ex10-2_017.jpg Edgar Link pending
ex10-2_018.jpg Edgar Link pending
ex10-2_019.jpg Edgar Link pending
ex10-2_020.jpg Edgar Link pending
ex10-2_021.jpg Edgar Link pending
ex10-2_022.jpg Edgar Link pending
ex10-2_023.jpg Edgar Link pending
ex10-2_024.jpg Edgar Link pending
ex10-3.htm Edgar Link pending
ex10-3_001.jpg Edgar Link pending
ex10-3_002.jpg Edgar Link pending
ex10-3_003.jpg Edgar Link pending
ex10-3_004.jpg Edgar Link pending
ex10-3_005.jpg Edgar Link pending
ex10-3_006.jpg Edgar Link pending
ex10-3_007.jpg Edgar Link pending
ex10-3_008.jpg Edgar Link pending
ex10-3_009.jpg Edgar Link pending
ex10-3_010.jpg Edgar Link pending
ex10-3_011.jpg Edgar Link pending
ex10-3_012.jpg Edgar Link pending
ex10-3_013.jpg Edgar Link pending
ex10-3_014.jpg Edgar Link pending
ex10-3_015.jpg Edgar Link pending
ex10-3_016.jpg Edgar Link pending
ex10-3_017.jpg Edgar Link pending
ex10-3_018.jpg Edgar Link pending
ex10-4.htm Edgar Link pending
ex10-4_001.jpg Edgar Link pending
ex10-4_002.jpg Edgar Link pending
ex10-4_003.jpg Edgar Link pending
ex10-4_004.jpg Edgar Link pending
ex10-4_005.jpg Edgar Link pending
ex10-4_006.jpg Edgar Link pending
ex10-4_007.jpg Edgar Link pending
ex10-4_008.jpg Edgar Link pending
ex10-4_009.jpg Edgar Link pending
ex10-4_010.jpg Edgar Link pending
ex10-4_011.jpg Edgar Link pending
ex10-4_012.jpg Edgar Link pending
ex10-4_013.jpg Edgar Link pending
ex10-4_014.jpg Edgar Link pending
ex10-4_015.jpg Edgar Link pending
ex10-4_016.jpg Edgar Link pending
ex10-4_017.jpg Edgar Link pending
ex10-4_018.jpg Edgar Link pending
ex10-4_019.jpg Edgar Link pending
ex10-4_020.jpg Edgar Link pending
ex10-4_021.jpg Edgar Link pending
ex10-4_022.jpg Edgar Link pending
ex10-4_023.jpg Edgar Link pending
ex10-4_024.jpg Edgar Link pending
ex10-4_025.jpg Edgar Link pending
ex10-5.htm Edgar Link pending
ex10-5_001.jpg Edgar Link pending
ex10-5_002.jpg Edgar Link pending
ex10-5_003.jpg Edgar Link pending
ex10-5_004.jpg Edgar Link pending
ex10-5_005.jpg Edgar Link pending
ex10-5_006.jpg Edgar Link pending
ex10-5_007.jpg Edgar Link pending
ex10-5_008.jpg Edgar Link pending
ex10-5_009.jpg Edgar Link pending
ex10-5_010.jpg Edgar Link pending
ex10-5_011.jpg Edgar Link pending
ex10-5_012.jpg Edgar Link pending
ex10-5_013.jpg Edgar Link pending
ex10-5_014.jpg Edgar Link pending
ex10-5_015.jpg Edgar Link pending
ex10-5_016.jpg Edgar Link pending
ex10-5_017.jpg Edgar Link pending
ex10-5_018.jpg Edgar Link pending
ex10-5_019.jpg Edgar Link pending
ex10-5_020.jpg Edgar Link pending
ex10-5_021.jpg Edgar Link pending
ex10-5_022.jpg Edgar Link pending
ex10-5_023.jpg Edgar Link pending
ex10-5_024.jpg Edgar Link pending
ex10-6.htm Edgar Link pending
ex10-6_001.jpg Edgar Link pending
ex10-6_002.jpg Edgar Link pending
ex10-6_003.jpg Edgar Link pending
ex10-6_004.jpg Edgar Link pending
ex10-6_005.jpg Edgar Link pending
ex10-6_006.jpg Edgar Link pending
ex10-6_007.jpg Edgar Link pending
ex10-6_008.jpg Edgar Link pending
ex10-6_009.jpg Edgar Link pending
ex10-6_010.jpg Edgar Link pending
ex10-6_011.jpg Edgar Link pending
ex10-6_012.jpg Edgar Link pending
ex10-6_013.jpg Edgar Link pending
ex10-6_014.jpg Edgar Link pending
ex10-6_015.jpg Edgar Link pending
ex10-6_016.jpg Edgar Link pending
ex10-6_017.jpg Edgar Link pending
ex10-6_018.jpg Edgar Link pending
ex10-7.htm Edgar Link pending
ex10-7_001.jpg Edgar Link pending
ex10-7_002.jpg Edgar Link pending
ex10-7_003.jpg Edgar Link pending
ex10-7_004.jpg Edgar Link pending
ex10-7_005.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable